6-APDB

Under the Controlled Substance Analogue Enforcement Act of 1986, 6-APDB may be treated as a Schedule I controlled substance only when it satisfies the federal analogue definition and exclusions and is intended for human consumption. In that circumstance, the federal offense provisions governing possession, manufacture, distribution, dispensing, and possession with intent to manufacture, distribute, or dispense apply. 6-APDB is not separately named in the current federal controlled-substance schedules.

6-APDB is covered as an amphetamine analogue under item 19 of Schedule I to the Controlled Drugs and Substances Act, rather than being expressly named in the schedule. This classification has applied since 6 November 2012 and is based on the Act's definition of an analogue as a substance with a substantially similar chemical structure to a controlled substance. Unauthorized possession, trafficking, possession for trafficking, import, export, and production are prohibited, subject to statutory and regulatory authorizations and exceptions.

6-APDB is classified as a narcotic in Annex IV of the Arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants, as amended by the order of 3 May 2018. The classification took effect on 9 May 2018. Annex IV expressly lists 6-APDB under the names 4-desoxy-MDA, 6-(2-aminopropyl)-2,3-dihydrobenzofurane, and 1-(2,3-dihydro-1-benzofuran-6-yl)propan-2-amine; it also covers qualifying alpha-ethylamine derivatives of the 2,3-dihydrobenzofuran nucleus.

6-APDB falls within Anlage 1 Nr. 1 of the Neue-psychoaktive-Stoffe-Gesetz as a 2-phenethylamine derivative covered by its generic structural definition, in force since 26 November 2016. Section 3 prohibits trade, placing on the market, manufacture, import, export, transit, acquisition, possession, and administration to another person, subject to recognized commercial, industrial, scientific, and specified official-use exceptions and statutory product exclusions. Under section 4(1), trade, placing on the market, administration, and manufacture or movement into Germany for the purpose of placing on the market are punishable by imprisonment for up to three years or a fine; simple acquisition and possession are prohibited but are not standalone criminal offences.

6-APDB is listed by both its common name and the chemical name 6-(2-aminopropil)-2,3-diidrobenzofurano in Tabella I of Decreto del Presidente della Repubblica 9 ottobre 1990, n. 309. Its listing took effect on 23 July 2013 under the Decreto del Ministero della salute 25 giugno 2013 and was preserved when the scheduling framework was restored in 2014. The operative Article 73(1)—the pre-2006 text revived by Constitutional Court judgment no. 32/2014—covers unauthorized cultivation, production, manufacture, extraction, refining, sale, offering for sale, transfer, receipt, distribution, trade, acquisition, transport, export, import, procurement for others, sending, transshipment, delivery, and possession of a Tabella I substance outside the personal-use cases governed by Article 75. For a non-minor Article 73(1) offence, the penalty is imprisonment for six to twenty years, following Constitutional Court judgment no. 40/2019, and a fine of EUR 25,822 to EUR 258,228. Article 73(1-bis) is not the current basis for non-personal-use acquisition, import, export, receipt, or possession.

6-APDB has been listed as 1-(2,3-dihydro-1-bensofuran-6-yl)propan-2-amin in the annex to Förordning (1999:58) om förbud mot vissa hälsofarliga varor since 9 June 2015. Without a permit, it may not be imported, transferred, manufactured, acquired for transfer, handled when not intended for personal use, offered for sale, or possessed. Permits may be issued for scientific or industrial purposes, and the listing also covers salts when they can exist.

6-APDB is listed by its name and systematic chemical identity in item 100 of Annex 6, Verzeichnis e of the BetmVV-EDI, effective since 1 December 2012. Verzeichnis e substances are subject to the control measures applicable to Verzeichnis a narcotics. Cultivation, manufacture, import, export, storage, use, or placing on the market without authorization is punishable by up to three years' imprisonment or a monetary penalty under Articles 7 and 20 of the BetmG.

6-APDB is controlled as a Class B drug under Schedule 2 Part II paragraph 1(e) of the Misuse of Drugs Act 1971 through the generic definition for compounds structurally derived from 2,3-dihydro-1-benzofuran with the specified 2-ethylamino substituent. This permanent Class B classification took effect on 10 June 2014; 6-APDB is not individually named in the schedule. Subject to applicable regulations, licences, exceptions and statutory defences, the Act restricts possession, possession with intent to supply, production, supply, offers to supply, import and export.